A detailed history of Signaturefd, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 1,952 shares of AXGN stock, worth $33,496. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,952
Previous 1,952 -0.0%
Holding current value
$33,496
Previous $27,000 18.52%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

SELL
$8.14 - $12.25 $407 - $612
-50 Reduced 2.5%
1,952 $23,000
Q2 2022

Aug 10, 2022

BUY
$6.99 - $10.0 $349 - $500
50 Added 2.56%
2,002 $16,000
Q4 2018

Feb 13, 2019

SELL
$17.09 - $38.25 $14,560 - $32,589
-852 Reduced 30.39%
1,952 $40,000
Q3 2018

Nov 15, 2018

BUY
$34.05 - $55.9 $13,109 - $21,521
385 Added 15.92%
2,804 $103,000
Q2 2018

Aug 14, 2018

SELL
$36.15 - $52.5 $939 - $1,365
-26 Reduced 1.06%
2,419 $122,000
Q1 2018

May 08, 2018

BUY
$24.4 - $40.25 $59,658 - $98,411
2,445 New
2,445 $89,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $726M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.